OTX015 targets and inhibits canonical NF-κB, TLR and JAK/STAT3 signaling pathways, as well as c-MYC- and E2F1-regulated genes in DLBCL in vitro and in vivo [407]. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.